Cargando…
USP22 promotes HER2-driven mammary carcinoma aggressiveness by suppressing the unfolded protein response
The Ubiquitin-Specific Protease 22 (USP22) is a deubiquitinating subunit of the mammalian SAGA transcriptional co-activating complex. USP22 was identified as a member of the so-called “death-from-cancer” signature predicting therapy failure in cancer patients. However, the importance and functional...
Autores principales: | Prokakis, Evangelos, Dyas, Anna, Grün, Regina, Fritzsche, Sonja, Bedi, Upasana, Kazerouni, Zahra B., Kosinsky, Robyn L., Johnsen, Steven A., Wegwitz, Florian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195738/ https://www.ncbi.nlm.nih.gov/pubmed/34007022 http://dx.doi.org/10.1038/s41388-021-01814-5 |
Ejemplares similares
-
USP22-dependent HSP90AB1 expression promotes resistance to HSP90 inhibition in mammary and colorectal cancer
por: Kosinsky, Robyn Laura, et al.
Publicado: (2019) -
The histone H2B ubiquitin ligase RNF40 is required for HER2-driven mammary tumorigenesis
por: Wegwitz, Florian, et al.
Publicado: (2020) -
Usp22 deficiency impairs intestinal epithelial lineage specification in vivo
por: Kosinsky, Robyn L., et al.
Publicado: (2015) -
USP22 Suppresses SPARC Expression in Acute Colitis and Inflammation-Associated Colorectal Cancer
por: Kosinsky, Robyn Laura, et al.
Publicado: (2021) -
HDAC8 suppresses the epithelial phenotype and promotes EMT in chemotherapy-treated basal-like breast cancer
por: Pantelaiou-Prokaki, Garyfallia, et al.
Publicado: (2022)